About 50 results
Open links in new tab
  1. Generic Drugs: Questions & Answers | FDA

    Generic Drug Facts At-a-glance information on generic medicines, including why they may look different or cost less than brand-name medicines.

  2. Generic Drugs | FDA

    Mar 13, 2025 · Understanding generic drugs. Consumer-friendly information on the safe and effective use of generic drugs.

  3. Overview & Basics | FDA

    Sep 16, 2025 · Detailed information on FDA's rigorous review process for generic drugs Generic Competition and Drug Prices Information on how the introduction of generics leads to lower prices for …

  4. FDA List of Authorized Generic Drugs

    The FDA List of Authorized Generics page answers what an authorized generic is and how it differs from a traditional generic. An authorized generic is used to describe an approved brand name drug ...

  5. Generic Drug Facts | FDA

    Nov 1, 2021 · Generic drugs: Get the facts. Consumer-friendly text and graphics provide a few facts about generic drug approval, quality, and performance.

  6. This list of authorized generic drugs (AGs) was created from a manual review of FDA’s database of annual reports submitted to the FDA since January 1, 1999 by sponsors of new drug applications ...

  7. Office of Generic Drugs 2022 Annual Report | FDA

    In 2022, generic drugs remained a significant public health priority for the FDA. Competition from generic drug makers helped make drugs more widely available and generally less expensive ...

  8. This list of authorized generic drugs (AGs) was created from a manual review of FDA’s database of annual reports submitted to the FDA since January 1, 1999 by sponsors of new drug applications ...

  9. Biosimilars Basics for Patients | FDA

    Biosimilars are safe and effective medications for treating many illnesses such as arthritis and cancer. Learn about biosimilars and how they benefit patients.

  10. First Generic Drug Approvals | FDA

    Oct 23, 2025 · FDA considers first generics to be important to public health, and prioritizes review of these submissions.